Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

World Courier (UK) Ltd

World Courier is a provider of premium logistics services and the leading global specialty supplier of transportation, storage and distribution services for multinational biopharmaceutical clinical trials. Our service offerings include temperature-controlled and time-critical handling and transportation, temperature-controlled storage and distribution, specialized packaging, and customs brokerage services. Our services are utilized by over five hundred biopharmaceutical companies, including each of the top 50 global players, as well as all major Contract Research Organizations, Clinical Trial Suppliers and Central Labs.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

World Courier (UK) Ltd
8th Floor, Sea Containers House, 20 Upper Ground, London, SE1 9PD, United Kingdom
+44 (0)20 7928 7256
Contact World Courier (UK) Ltd
Website

 Latest Content from PMHub 

First impressions matter: Why getting your onboarding right is key for digital engagement

Press Releases | January 20, 2026 | Graphite Digital

As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs not only meet regulatory standards,...

How can pharma build genuine partnerships with patient communities?

White Papers and Resources | January 19, 2026 | Amiculum

Patient engagement is not optional in pharma – it’s integral. Meaningful partnerships with patients, caregivers and advocates must shape every stage of healthcare and medicines development, driving better outcomes, equity...

How will AI change field training?

White Papers and Resources | January 15, 2026 | Inizio

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

The Heart and Mouth Connection Every Woman Needs to Know

Press Releases | January 9, 2026 | Medscape Education

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Press Releases | January 7, 2026 | Inizio

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

White Papers and Resources | January 7, 2026 | Inizio

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

Press Releases | January 6, 2026 | Medscape Education

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Five Predictions That Will Reshape Biopharma Commercialisation in 2026

White Papers and Resources | January 5, 2026 | Nmblr

Every year, we’re met with restructuring, hiring freezes, and portfolio cuts. And every year we tell ourselves the same story. It’s a rough patch. A cycle that will reverse. But...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Press Releases | December 23, 2025 | Medscape Education

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.

Does Rare Disease Education Work?

Press Releases | December 23, 2025 | Medscape Education

For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.